Dr. Ingmar Gorman

<p>In this episode of the Psychedelic Spotlight podcast, we speak with Dr. Ingmar Gorman who is the Co-Founder and Lead Trainer at Fluence, and a Principal Investigator for the Multidisciplinary Association for Psychedelic Studies ("MAPS").</p><p>In our conversation with Dr. Gorman, we learn about the educational and training resources Fluence is focused on developing to address the growing interest in psychedelic integration and psychedelic-assisted psychotherapy. Dr. Gorman is also kind enough to share his expertise and perspective as it relates to the encouraging results recently released surrounding the Phase 3 Trials testing MDMA-assisted psychotherapy for PTSD conducted by MAPS, and what it potentially means for the future of MDMA-assisted psychotherapy.</p><p>*To learn more about the company featured in this episode and the work they’re doing, visit their website: <a href="https://www.fluencetraining.com/">FluenceTraining.com</a></p><p>*Get the latest industry news around all things psychedelics by visiting our website and be sure to subscribe to our newsletter to never miss a thing. </p><p>Visit our Website: <a href="https://psychedelicspotlight.com/">PsychedelicSpotlight.com</a></p><p>Subscribe to our <a href="https://bit.ly/3prTiCI">YouTube Channel</a></p><p>Follow us on <a href="https://www.instagram.com/psycspotlight/">Instagram</a></p><p>Like us on <a href="https://www.facebook.com/PsychedelicSpotlight/">Facebook</a></p><p>Follow us on <a href="https://twitter.com/PsycSpotlight">Twitter</a></p><p>*This episode was recorded on May 19, 2021.</p>